Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-19

Clinical Trial Update: MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for MH004 Ointment in healthy volunteers and adults with mild to moderate atopic dermatitis, covering Phase 1 and Phase 2 studies that hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MH004 Ointment

Snippet

Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd | Conditions: Atopic Dermatitis (AD) | Phase 1, Phase 2 | Status: COMPLETED